Compare CIEN & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CIEN | LNTH |
|---|---|---|
| Founded | 1992 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.0B | 6.5B |
| IPO Year | 1996 | 2014 |
| Metric | CIEN | LNTH |
|---|---|---|
| Price | $567.40 | $99.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $382.69 | $87.00 |
| AVG Volume (30 Days) | ★ 1.8M | 977.3K |
| Earning Date | 06-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.55 | N/A |
| EPS | 1.03 | ★ 1.80 |
| Revenue | ★ $4,769,507,000.00 | $343,374,000.00 |
| Revenue This Year | $30.83 | N/A |
| Revenue Next Year | $19.87 | $14.19 |
| P/E Ratio | $553.83 | ★ $55.18 |
| Revenue Growth | ★ 18.79 | 3.62 |
| 52 Week Low | $70.77 | $47.27 |
| 52 Week High | $605.61 | $102.66 |
| Indicator | CIEN | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 55.76 | 67.78 |
| Support Level | $457.71 | $91.65 |
| Resistance Level | $598.84 | N/A |
| Average True Range (ATR) | 34.18 | 3.13 |
| MACD | -3.44 | 0.17 |
| Stochastic Oscillator | 65.66 | 66.35 |
Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.